Explore more publications!

Press Releases

Appeals court prevents cuts to billions in medical and public health research funding

Appeals court prevents cuts to billions in medical and public health research funding

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. – AVXL
US Consumer Technology Sales Forecast to Reach $112 Billion in 2026, Reports Circana
Earth Science Tech, Inc. (ETST) Issues Directive Industry Classification Update to SIC 2834; Formally Identifies as Pharmaceutical Entity Since 2022
Blank Rome Welcomes Leading Intellectual Property & Technology Partners in South Florida
Earth Science Tech, Inc. (ETST) Engages Hayden IR, Expanding Investor Relations Efforts to Support its Investor Outreach and Communications
Berger Montague PC Investigates Uber Technologies, Inc.’s Board of Directors for Breach of Fiduciary Duty (NYSE: UBER)
Violet Grace Interiors Announces New Private Design Studio in Hinsdale, Illinois
NXP and GE HealthCare Accelerate AI Innovation in Acute Care
Suite Home Celebrates 20 Years of Growth, Team Excellence, and Trusted Furnished Living
Public Relations Pros Share 2026 PR Trends
Built In honors Dscout in its esteemed 2026 Best Places to Work Awards
Remix Therapeutics Appoints Mythili Koneru, MD, PhD, as Chief Medical Officer
Sphera Named a Built In 2026 Best Places to Work Winner
Chicago's Healthcare Industry Insights: Stats & Trends by Local Blacksmith Agency
XA Investments Interval Fund (OCTIX) Now Available for Purchase on Charles Schwab
Ingredion & GATX Roll Out Heart Health Railcar Supporting American Heart Association
Blue Creative Consulting Expands with SERHANT. and RAZR Group Under Leadership of Edmund Hodges
GTreasury Acquires Solvexia to Revolutionize Reconciliation and Regulatory Reporting
Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions